NR4A1 and triple-negative breast carcinoma: Various studies showed that therapy response and outcome of patients with tumors showing low hormone receptor expression between 1 and 10% (LowHR) are more similar to triple negative breast cancer (TNBC), the so-called basal subtype [6–13].